LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Kodu・Aktsiate loetelu・Pulse Biosciences Inc

Pulse Biosciences Inc

Suletud

SektorTervishoid

19.26 0.36

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.65

Max

19.26

Põhinäitajad
By Trading Economics
Sissetulek	2M -17M
Müük	178K 264K
Aktsiakasum	-0.29
Kasumimarginaal	-6,603.409
Töötajad	116
EBITDA	-2M -21M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+56.17% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-179M 958M
Eelmine avamishind	18.9
Eelmine sulgemishind	19.26

Uudiste sentiment

By Acuity

84%

16%

336 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. veebr 2026, 22:04 UTC

Tulu

Coles 1st Half Net Profit Falls 11% on Worker Remediation Costs

26. veebr 2026, 23:55 UTC

Market Talk

Gold Edges Higher as Traders Digest U.S.-Iran Talks -- Market Talk

26. veebr 2026, 23:40 UTC

Omandamised, ülevõtmised, äriostud

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- Update

26. veebr 2026, 23:37 UTC

Market Talk

Japanese Stocks May Fall, Tracking Wall Street's Decline -- Market Talk

26. veebr 2026, 23:32 UTC

Tulu

Why Nvidia's Huge Numbers Don't Settle the Latest AI Fears -- Heard on the Street -- WSJ

26. veebr 2026, 23:19 UTC

Omandamised, ülevõtmised, äriostud

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26. veebr 2026, 23:18 UTC

Omandamised, ülevõtmised, äriostud

Paramount Wins Bidding War for Warner Discovery After Netflix Drops Out -- WSJ

26. veebr 2026, 23:12 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

26. veebr 2026, 23:12 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Netflix Gives Up in Bidding War Over Warner -- Market Talk

26. veebr 2026, 23:01 UTC

Omandamised, ülevõtmised, äriostud

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26. veebr 2026, 23:00 UTC

Omandamised, ülevõtmised, äriostud

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26. veebr 2026, 23:00 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26. veebr 2026, 22:55 UTC

Omandamised, ülevõtmised, äriostud

Netflix Declines to Match Paramount's Offer for Warner Bros. -- Barrons.com

26. veebr 2026, 22:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

26. veebr 2026, 22:43 UTC

Market Talk

RBA Hike In March Is Being Underpriced -- Market Talk

26. veebr 2026, 22:33 UTC

Omandamised, ülevõtmised, äriostud

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26. veebr 2026, 22:20 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- Update

26. veebr 2026, 22:13 UTC

Market Talk

Omandamised, ülevõtmised, äriostud

Bidding War Over Warner Bros. Set to Continue -- Market Talk

26. veebr 2026, 21:59 UTC

Tulu

D-Wave Quantum Stock Rises on Earnings. Why a Revenue Miss Doesn't Seem to Matter. -- Barrons.com

26. veebr 2026, 21:58 UTC

Omandamised, ülevõtmised, äriostud

Netflix Has 4 Days to Make a New Offer for Warner Bros. The Bidding War Continues. -- Barrons.com

26. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

26. veebr 2026, 21:49 UTC

Tulu

Coles 1H Net Profit Falls 11% on Worker Remediation Costs

26. veebr 2026, 21:45 UTC

Tulu

Coles Expects One-Off Costs of Around A$7 Million in 1H to Complete Simplification Process

26. veebr 2026, 21:44 UTC

Tulu

Coles Says Liquor Sales Fell 2.5% in First Seven Weeks of 3Q

26. veebr 2026, 21:44 UTC

Tulu

Coles Expects Market to Remain Highly Competitive

26. veebr 2026, 21:44 UTC

Tulu

Coles Says Supermarket Customers Remain Value Oriented

26. veebr 2026, 21:43 UTC

Tulu

Coles Says Supermarket Sales Revenue Up 5.3% in First Seven Weeks of 3Q When Tobacco Excluded

26. veebr 2026, 21:43 UTC

Tulu

Coles Says Supermarket Sales Revenue Up 3.7% in First Seven Weeks of 3Q

26. veebr 2026, 21:42 UTC

Omandamised, ülevõtmised, äriostud

Warner Discovery Says Paramount's Latest Bid Is Superior to Netflix Deal -- WSJ

26. veebr 2026, 21:41 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Warner Bros. Earnings Report Falls Short. What It Means for the Netflix Takeover Saga. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

56.17% tõus

12 kuu keskmine prognoos

Keskmine 30 USD 56.17%

Kõrge 30 USD

Madal 30 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

336 / 352 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.